CTAD
December 01, 2025 NeuroScios is attending the 18th Clinical Trials on Alzheimer's Disease (CTAD) conference, 01DEC-04DEC 2025, in San Diego, USA.Meet up with Chief Commercial Officer, Casper Clemmensen and the business development team.
Contact: ccl@sanos.com
Read more and sign up for the conference here